URI
URI Label
Revisions
Add to List
Edit Entry
Export:
XML
- November 2017 (1)
- August 2017 (1)
- February 2017 (1)
- January 2017 (2)
- June 2016 (1)
- May 2016 (1)
- December 2015 (1)
- November 2015 (2)
- September 2015 (1)
- July 2015 (1)
- June 2015 (3)
- May 2015 (1)
- January 2015 (1)
- December 2014 (1)
- November 2014 (2)
- September 2014 (4)
- August 2014 (2)
- July 2014 (3)
- June 2014 (1)
- May 2014 (3)
- April 2014 (2)
- February 2014 (2)
- January 2014 (1)
- December 2013 (2)
- November 2013 (3)
- October 2013 (1)
- September 2013 (1)
- August 2013 (2)
- July 2013 (2)
- May 2013 (1)
- April 2013 (1)
- February 2013 (2)
- January 2013 (1)
- December 2012 (2)
- November 2012 (1)
- October 2012 (2)
- July 2012 (2)
- May 2012 (4)
- April 2012 (2)
- March 2012 (2)
- January 2012 (3)
- 3D7 IC50 Avery Lab (3)
- AstraZeneca (2)
- MetID (3)
- Potencies GSK (1)
- Potencies Guy (1)
- Syngene (8)
- UCSD (1)
- Biology (37)
- DMPK (2)
- Dundee (4)
- GSH-EE - Chapman Lab (2)
- GSK PRR Assay (1)
- Imperial DGFA (1)
- Kirk Lab (5)
- Metabolism (1)
Show/Hide Keys
Glutathione Trapping Study for OSM-S-35
Results
Conclusion
We’ve run the glutathione trapping study for OSM-S-35 in the presence of metabolic activation (i.e. human microsomes). We also included a search for other potential metabolites formed. A number of metabolites were detected, mainly oxygenated species (mono, bis and tri-oxygenated metabolites) with the predominant metabolite (based on peak area and assuming similar response factors for each metabolite) arising from likely hydroxylation of the pyrrole substituted benzene. In the presence of GSH-EE, adducts were observed both in the presence and absence of metabolic activation. The results are summarised in the attached file. Please let me or Sue know if you have any questions or comments
MHT The meaning. Various oxygenated metabolites are proposed, but is their level (after the given time) unusual? Is this compound metabolised relatively quickly?
KW This study was not designed to look at the rate of degradation. We run this under conditions to maximise metabolism so that we can detect metabolites. The previous study (MMV_OSDD_12_001) was conducted to look at the rate of metabolism, and in that study this compound degraded with a moderately fast rate.
MHT The lack of difference in the presence of GSH-EE - does this imply that the double C=C bond of the thiazolidinone is not reacting in the way one might expect it to? i.e. it's not a Michael acceptor? i.e. no "trapping"?
KW I assume you are referring to the comment about GSH not affecting the extent of loss of parent? This comments just means that GSH-EE did not accelerate the rate of degradation but you cannot conclude that there is no trapping. See further down in the table where a conjugate was found for the parent (although the signal was weak) and for +16 and +32 metabolites.
MHT Are there any other results here that are red flags to you, but that I'm missing through inexperience in looking at data of this kind?
KW The fact that GSH-EE conjugates were trapped for the metabolites is not a good sign and suggests that the metabolites could be “reactive” with nucleophiles such as glutathione.